Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Whitman, S. P.
Right arrow Articles by Caligiuri, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whitman, S. P.
Right arrow Articles by Caligiuri, M. A.
[Cancer Research 61, 59-63, January 1, 2001]
© 2001 American Association for Cancer Research


Advances in Brief

The Partial Nontandem Duplication of the MLL (ALL1) Gene Is a Novel Rearrangement That Generates Three Distinct Fusion Transcripts in B-Cell Acute Lymphoblastic Leukemia1

Susan P. Whitman, Matthew P. Strout, Guido Marcucci, Aharon G. Freud, Lucia L. Culley, Nancy J. Zeleznik-Le, Krzysztof Mrózek, Karl S. Theil, Ursula R. Kees, Clara D. Bloomfield and Michael A. Caligiuri2

Divisions of Hematology and Oncology [S. P. W., G. M., M. A. C.] and Human Cancer Genetics [M. P. S., A. G. F., M. A. C.], Department of Pathology [L. L. C., K. S. T.] and Comprehensive Cancer Center [K. M., C. D. B., M. A. C.], The Ohio State University, Columbus, Ohio 43210; Department of Medicine [N. J. Z.], Loyola University of Chicago, Cardinal Bernadin Cancer Center, Maywood, Illinois 60153; and TVWT Institute for Child Health Research [U. R. K.], University of Western Australia, Perth, Western Australia 6008

A partial nontandem duplication (PNTD) of mixed lineage leukemia (MLL) gene is described in B-cell acute lymphoid leukemia without structural cytogenetic abnormalities at 11q23 and 9p22. A duplicated portion of MLL is interrupted by the insertion of a region of 9p22 that includes the 3'-end of the AF9 gene. The PNTD encodes: (a) a PNTD transcript; (b) a partial tandem duplication of MLL; and (c) a chimeric transcript fusing MLL to the 3'-end of AF9, mimicking the t(9;11)(p22;q23) and expressed 1024-fold higher than the other two. The MLL PNTD, therefore, contributes toward leukemogenesis through simultaneous production of fusion transcripts that are otherwise encoded by three distinct genetic defects.




This article has been cited by other articles:


Home page
Hum Mol GenetHome page
A. Miremadi, M. Z. Oestergaard, P. D.P. Pharoah, and C. Caldas
Cancer genetics of epigenetic genes
Hum. Mol. Genet., April 15, 2007; 16(R1): R28 - R49.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Libura, D. J. Slater, C. A. Felix, and C. Richardson
Therapy-related acute myeloid leukemia-like MLL rearrangements are induced by etoposide in primary human CD34+ cells and remain stable after clonal expansion
Blood, March 1, 2005; 105(5): 2124 - 2131.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C.-K. So, Y. Nie, Y. Song, G.-Y. Yang, S. Chen, C. Wei, L.-D. Wang, N. A. Doggett, and C. S. Yang
Loss of Heterozygosity and Internal Tandem Duplication Mutations of the CBP Gene Are Frequent Events in Human Esophageal Squamous Cell Carcinoma
Clin. Cancer Res., January 1, 2004; 10(1): 19 - 27.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
X. J. de Mollerat, F. Gurrieri, C. T. Morgan, E. Sangiorgi, D. B. Everman, P. Gaspari, J. Amiel, M. J. Bamshad, R. Lyle, J.-L. Blouin, et al.
A genomic rearrangement resulting in a tandem duplication is associated with split hand-split foot malformation 3 (SHFM3) at 10q24
Hum. Mol. Genet., August 15, 2003; 12(16): 1959 - 1971.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
U. R. Kees, J. Ford, M. Watson, A. Murch, M. Ringner, R. L. Walker, and P. Meltzer
Gene Expression Profiles in a Panel of Childhood Leukemia Cell Lines Mirror Critical Features of the Disease
Mol. Cancer Ther., July 1, 2003; 2(7): 671 - 677.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. G. Blanco, T. Dervieux, M. J. Edick, P. K. Mehta, J. E. Rubnitz, S. Shurtleff, S. C. Raimondi, F. G. Behm, C.-H. Pui, and M. V. Relling
Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemia
PNAS, August 28, 2001; 98(18): 10338 - 10343.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.